Cargando…
A Prognostic Gene Signature for Hepatocellular Carcinoma
Hepatocellular carcinoma is the third most common cause of cancer-related deaths in China and immune-based therapy can improve patient outcomes. In this study, we investigated the relationship between immunity-associated genes and hepatocellular carcinoma from the prognostic perspective. The data do...
Autores principales: | Chen, Rong, Zhao, Meng, An, Yanli, Liu, Dongfang, Tang, Qiusha, Teng, Gaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091376/ https://www.ncbi.nlm.nih.gov/pubmed/35574316 http://dx.doi.org/10.3389/fonc.2022.841530 |
Ejemplares similares
-
GBAP1 functions as a tumor promotor in hepatocellular carcinoma via the PI3K/AKT pathway
por: Chen, Rong, et al.
Publicado: (2023) -
A prognostic signature of cuproptosis and TCA-related genes for hepatocellular carcinoma
por: Zhang, Qi, et al.
Publicado: (2022) -
Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular Carcinoma
por: Yuan, Chaoyan, et al.
Publicado: (2021) -
Autophagy-Related Signatures as Prognostic Indicators for Hepatocellular Carcinoma
por: Ye, Wen, et al.
Publicado: (2022) -
Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)